HA
REGN icon

H2O AM’s Regeneron Pharmaceuticals REGN Stock Holding History

H2O AM’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,673
Closed -$2.28M – 166
2020
Q1 		$2.28M Sell
4,673
-26,419
-85% -$10.9M 1.81% 15
2019
Q4 		$11.7M Sell
31,092
-8,101
-21% -$2.73M 2.77% 10
2019
Q3 		$10.9M Sell
39,193
-12,670
-24% -$3.75M 1.86% 21
2019
Q2 		$16.2M Buy
51,863
+12,581
+32% +$4.19M 1.36% 28
2019
Q1 		$16.1M Buy
39,282
+27,282
+227% +$11.2M 2.02% 14
2018
Q4 		$4.35M Buy
+12,000
New +$4.39M 0.48% 41

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

H2O AM's REGN Position: Q2 2020 in Review

H2O AM sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 4,673 shares — an estimated $2.28M sold.

H2O AM first reported a position in REGN in Q4 2018 and held it in 6 quarters. The position peaked at $16.2M in Q2 2019. 933 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • H2O AM reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • H2O AM sold 4,673 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $2.28M.
  • H2O AM first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 6 quarters.
  • H2O AM's Regeneron Pharmaceuticals position peaked at $16.2M in Q2 2019.
  • 933 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on H2O AM's 13F filing for Q2 2020, filed 13 Aug 2020.